Vepdegestrant Outperforms Fulvestrant in Mutant ER+ Breast Cancer
In a groundbreaking development in the treatment of hormone receptor-positive breast cancer, recent findings have revealed that the novel PROTAC-based ...
In a groundbreaking development in the treatment of hormone receptor-positive breast cancer, recent findings have revealed that the novel PROTAC-based ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine